TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood
Active substance: ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, ADENINE
SOLUTION · ANHYDROUS CITRIC ACID 2.99 g/1000mL, TRISODIUM CITRATE DIHYDRATE 26.3 g/1000mL, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 2.22 g/1000mL, DEXTROSE MONOHYDRATE 31.9 g/1000mL, ADENINE .275 g/1000mL
United StatesActive
Marketing holder: Terumo Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ANHYDROUS CITRIC ACID · 2.99 g/1000mL
- TRISODIUM CITRATE DIHYDRATE · 26.3 g/1000mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · 2.22 g/1000mL
- DEXTROSE MONOHYDRATE · 31.9 g/1000mL
- ADENINE · .275 g/1000mL
Registration
- Registration number
- 53877-108
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 53877-108 · Verified 2026-10-09 · open in source